Relx Plc (NYSE:RELX) Shares Purchased by Zions Bancorporation N.A.

Zions Bancorporation N.A. boosted its stake in shares of Relx Plc (NYSE:RELX) by 69.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 69,710 shares of the technology company’s stock after acquiring an additional 28,454 shares during the quarter. Zions Bancorporation N.A.’s holdings in Relx were worth $3,166,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of RELX. Thrivent Financial for Lutherans raised its position in shares of Relx by 83.0% in the third quarter. Thrivent Financial for Lutherans now owns 10,665 shares of the technology company’s stock worth $506,000 after acquiring an additional 4,836 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Relx by 13.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock worth $5,709,000 after purchasing an additional 14,088 shares during the period. Eagle Asset Management Inc. boosted its position in Relx by 11.3% during the third quarter. Eagle Asset Management Inc. now owns 13,831 shares of the technology company’s stock worth $664,000 after purchasing an additional 1,406 shares in the last quarter. Raymond James Trust N.A. grew its holdings in Relx by 2.6% in the third quarter. Raymond James Trust N.A. now owns 15,631 shares of the technology company’s stock valued at $742,000 after purchasing an additional 399 shares during the period. Finally, Cerity Partners LLC grew its holdings in Relx by 106.8% in the third quarter. Cerity Partners LLC now owns 107,564 shares of the technology company’s stock valued at $5,105,000 after purchasing an additional 55,547 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.

Relx Price Performance

NYSE:RELX opened at $49.81 on Tuesday. The firm has a market cap of $92.45 billion, a P/E ratio of 26.78, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The stock has a 50 day moving average of $49.26 and a two-hundred day moving average of $47.73. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Relx Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. This represents a dividend yield of 1.6%. This is a boost from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. Relx’s payout ratio is presently 59.68%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Redburn Atlantic initiated coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock. Finally, Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.